Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Real World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development and Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development], End User - Forecast to 2027

Published by Meticulous Market Research Pvt. Ltd. Product code 973572
Published Content info 194 Pages
Delivery time: 1-2 business days
Price
Back to Top
Real World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development and Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development], End User - Forecast to 2027
Published: December 2, 2020 Content info: 194 Pages
Description

Real-World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development & Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development], End User - Forecast to 2027

The real-world evidence solutions market is expected to grow at a CAGR of 16.5% from 2020 to 2027 to reach USD 3.13 billion by 2027.

Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities. The growth in the real-world evidence solutions market is mainly attributed to the rising geriatric population and burden of chronic diseases, the shift towards value-based care, growing focus on personalized healthcare, delays in drug development and the subsequent increase in development costs, and expanding use of RWE for regulatory decision making. Moreover, growth opportunities in emerging markets; rising focus on end-to-end RWE services; and emerging roles of wearable devices, social media, and AI in RWE provide growth opportunities for players operating in the real-world evidence solutions market.

Based on component, in 2020, the datasets segment is expected to account for the largest share due to the increasing need for additional insights on epidemiology; compliance, adherence, and costs in a realistic environment; rise in demand for information by the payers, regulatory bodies, and providers with regards to drug safety; growing amount of medical data generated in hospitals and healthcare facilities; and increasing dependence on outcome-based studies on real-world data.

Based on application, the drug development and approvals segment is estimated to account for the largest share of the market in 2020. An increase in the demand of RWD and RWE to accelerate drug discovery & development, increasing investment by biopharmaceutical companies in R&D, and growing inclination of regulatory bodies towards RWE are expected to propel the growth of this segment.

In terms of end-users of real-world evidence solutions, pharmaceutical, biotech & medical device companies tend to use them extensively. The increasing importance of RWE studies in drug development and approvals, growing focus to avoid costly drug recalls, and the increasing need to assess drug performance in real-world settings are the factors driving this end-user segment.

An in-depth analysis of the real-world evidence solutions market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America is estimated to account for the largest share of the real-world evidence solutions market in 2020, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa.

The key players operating in the real-world evidence solutions market are Anthem, Inc. (U.S.), Clinigen Group plc (U.K.), Cognizant Technology Solutions Corporation (U.S.), IBM Corporation (U.S.), ICON plc (Ireland), IQVIA (U.S.), Optum (A Subsidiary of United Health Group, Inc.) (U.S.), Oracle Corporation (U.S.), PAREXEL International Corporation (U.S.), PerkinElmer, Inc. (U.S.), PPD Inc., (U.S.), SAS Institute Inc. (U.S.), and Syneos Health, Inc. (U.S.), among others.

Scope of the Report:

Real-world Evidence Solutions Market, by Component

  • Datasets
  • Disparate Datasets
  • EMR/EHR/Clinical data
  • Claims & Billing Data
  • Pharmacy Data
  • Product/Disease Registries Data
  • Other Disparate Datasets
  • Integrated Datasets
  • Services

Other disparate datasets comprise data gathered from other sources that can inform health statuses, such as mobile devices, wearable devices, and social media.

Real-world Evidence Solutions Market, by Application

  • Drug Development & Approvals
  • Oncology
  • Cardiovascular Disease
  • Neurology
  • Immunology
  • Others Therapeutic Areas

Other therapeutic areas comprise infectious diseases, musculoskeletal disorders, dermatological diseases, and respiratory diseases.

  • Medical Device Development & Approvals
  • Market Access & Reimbursement/Coverage Decisions
  • Clinical Decision-Making
  • Other Applications

Other applications comprise regulatory decision-making, post-approval monitoring, and post-market device surveillance.

Real-world Evidence Solutions Market, by End User

  • Pharmaceutical, Biotechnology & Medical Device Companies
  • Healthcare Payers
  • Healthcare Providers
  • Other End Users

Other end-users comprise academic research institutions, patient advocacy groups, regulators, and health technology assessment agencies.

Real-world Evidence Solutions Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • Japan
  • China
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa
Table of Contents

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Growing Burden of Chronic Diseases in Geriatric Population
    • 4.2.2. Delays in Drug Development and the Subsequent Increase in Development Costs
    • 4.2.3. Rising Focus Towards Personalized Healthcare
    • 4.2.4. Shift Towards Value-Based Care
    • 4.2.5. Impact Assessment of COVID-19
    • 4.2.6. Rapidly Growing Big Data in Healthcare
  • 4.3. Restraints
    • 4.3.1. Reluctance to Rely on Real-World Studies
  • 4.4. Challenges
    • 4.4.1. Lack of Standardized Methodologies to Develop RWE
  • 4.5. Opportunities
    • 4.5.1. Emerging Economies
    • 4.5.2. Rising Focus on End-to-End RWE Services
    • 4.5.3. Rising Adoption of Wearable Devices and Artificial Intelligence in RWE

5. Regulatory Analysis

  • 5.1. Introduction
  • 5.2. North America
  • 5.3. Europe
  • 5.4. Asia-Pacific
  • 5.5. Rest of the World

6. Pricing Models

  • 6.1. Introduction
  • 6.2. Pay Per Patient Record (Volume-Based Pricing)
  • 6.3. Pay Per Usage (Value-Based Pricing)
  • 6.4. Annual Subscription

7. Global Real-World Evidence Solutions Market, by Component

  • 7.1. Introduction
  • 7.2. Datasets
    • 7.2.1. Disparate Datasets
      • 7.2.1.1. EMR/EHR/Clinical Data
      • 7.2.1.2. Claims & Billing Data
      • 7.2.1.3. Pharmacy Data
      • 7.2.1.4. Product/Disease Registries Data
      • 7.2.1.5. Others
    • 7.2.2. Integrated Datasets
  • 7.3 Services

8. Global Real-World Evidence Solutions Market, by Application

  • 8.1. Introduction
  • 8.2. Drug Development & Approvals
    • 8.2.1 Oncology
    • 8.2.2 Cardiovascular Disease
    • 8.2.3 Neurology
    • 8.2.4 Immunology
    • 8.2.5 Others Therapeutic Areas
  • 8.3. Medical Device Development & Approvals
  • 8.4. Market Access & Reimbursement/Coverage Decisions
  • 8.5. Clinical Decision-Making
  • 8.6. Other Applications

9. Global Real-World Evidence Solutions Market, by End User

  • 9.1. Introduction
  • 9.2. Pharmaceutical, Biotechnology & Medical Device Companies
  • 9.3. Healthcare Payers
  • 9.4. Healthcare Providers
  • 9.5. Other End Users

10. Global Real-World Evidence Solutions Market, by Geography

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. Japan
    • 10.4.2. China
    • 10.4.3. Rest of Asia-Pacific
  • 10.5. Latin America
  • 10.6. Middle East & Africa

11. Competitive Landscape

  • 11.1. Introduction
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
    • 11.3.1. Competitive Benchmarking, by Methodology
  • 11.4. Market Share Analysis (2019)

12. Company Profiles

  • 12.1. IQVIA Holdings Inc. (U.S.)
  • 12.2. ICON plc (Ireland)
  • 12.3. Parexel International Corporation (U.S.)
  • 12.4. PPD Inc. (U.S.)
  • 12.5. International Business Machines Corporation (U.S.)
  • 12.6. UnitedHealth Group Incorporated (U.S.)
  • 12.7. Oracle Corporation (U.S.)
  • 12.8. SAS Institute Inc. (U.S.)
  • 12.9. Anthem Inc. (U.S.)
  • 12.10 Clinigen Group plc (U.K.)
  • 12.11 Cognizant Technology Solutions (CTS) Corporation
  • 12.12. PerkinElmer, Inc. (U.S.)

13. Appendix

  • 13.1. Questionnaire
  • 13.2. Available Customization

List of Tables

  • Table 1 Global Real-World Evidence Solutions Market Drivers: Impact Analysis (2020-2027)
  • Table 2 Global Real-World Evidence Solutions Market Restraints: Impact Analysis (2020-2027)
  • Table 3 Global Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 4 Global Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 5 Global Real-World Evidence Solutions Datasets Market Size, by Country/Region 2018-2027 (USD Million)
  • Table 6 Global Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 7 Global Real-World Evidence Solutions Disparate Datasets Market Size, by Country/Region, 2018-2027 (USD Million)
  • Table 8 Global EMR/EHR/Clinical Datasets Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 9 Global Claims & Billing Data Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 10 Global Pharmacy Data Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 11 Global Product/Disease Registries Data Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 12 Global Other Disparate Datasets Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 13 Global Real-World Evidence Solutions Integrated Datasets Market Size, by Country/Region, 2018-2027 (USD Million)
  • Table 14 Global Services Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 15 Global Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 16 Global RWE Solutions Market Size for Drug Development & Approvals, by Therapeutic Area, 2018-2027 (USD Million)
  • Table 17 Global RWE Solutions Market Size for Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 18 Global RWE Solutions Market Size for Oncological Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 19 Global RWE Solutions Market Size for Cardiovascular Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 20 Global RWE Solutions Market Size for Neurology Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 21 Global RWE Solutions Market Size for Immunology Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 22 Global RWE Solutions Market Size for Other Therapeutic Areas Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 23 Global RWE Solutions Market Size for Market Access & Reimbursement/Coverage Decisions, by Country/Region, 2018-2027 (USD Million)
  • Table 24 Global RWE Solutions Market Size for Clinical Decision Making, by Country/Region, 2018-2027 (USD Million)
  • Table 25 Global RWE Solutions Market Size for Medical Device Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 26 Global RWE Solutions Market Size for Other Applications, by Country/Region, 2018-2027 (USD Million)
  • Table 27 Global Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 28 Global Real-World Evidence Solutions Market Size, for Pharmaceutical, Biotechnology, and Medical Device Companies, by Country/Region, 2018-2027 (USD Million)
  • Table 29 Global Real-World Evidence Solutions Market Size, for Healthcare Payers, by Country/Region, 2018-2027 (USD Million)
  • Table 30 Global Real-World Evidence Solutions Market Size, for Healthcare Providers, by Country/Region, 2018-2027 (USD Million)
  • Table 31 Global Real-World Evidence Solutions Market Size, for Other End Users, by Country/Region, 2018-2027 (USD Million)
  • Table 32 Global Real-World Evidence Solutions Market Size, by Country/Region, 2018-2027 (USD Million)
  • Table 33 North America: Real-World Evidence Solutions Market Size, by Country, 2018-2027 (USD Million)
  • Table 34 North America: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 35 North America: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 36 North America: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 37 North America: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 38 North America: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 39 U.S.: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 40 U.S.: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 41 U.S.: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 42 U.S.: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 43 U.S.: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 44 Canada: Real -World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 45 Canada: Real -World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 46 Canada: Real -World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 47 Canada: Real -World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 48 Canada: Real -World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 49 European: Real-World Evidence Solutions Market Size, by Country, 2018-2027 (USD Million)
  • Table 50 European: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 51 European: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 52 European: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 53 European: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 54 European: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 55 Germany: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 56 Germany: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 57 Germany: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 58 Germany: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 59 Germany: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 60 U.K.: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 61 U.K.: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 62 U.K.: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 63 U.K.: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 64 U.K.: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 65 France: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 66 France: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 67 France: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 68 France: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 69 France: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 70 Italy: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 71 Italy: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 72 Italy: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 73 Italy: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 74 Italy: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 75 Spain: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 76 Spain: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 77 Spain: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 78 Spain: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 79 Spain: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 80 RoE: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 81 RoE: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 82 RoE: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 83 RoE: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 84 RoE: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 85 Asia-Pacific: Real-World Evidence Solutions Market Size, by Country, 2018-2027 (USD Million)
  • Table 86 Asia-Pacific: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 87 Asia-Pacific: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 88 Asia-Pacific: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 89 Asia-Pacific: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 90 Asia-Pacific: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 91 Japan: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 92 Japan: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 93 Japan: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 94 Japan: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 95 Japan: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 96 China: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 97 China: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 98 China: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 99 China: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 100 China: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 101 RoAPAC: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 102 RoAPAC: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 103 RoAPAC: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 104 RoAPAC: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 105 RoAPAC: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 106 Latin America: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 107 Latin America: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 108 Latin America: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 109 Latin America: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 110 Latin America: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 111 Middle East & Africa: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 112 Middle East & Africa: Real-World Evidence Solutions Datasets Market Size, by Type, 2018- 2027 (USD Million)
  • Table 113 Middle East & Africa: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 114 Middle East & Africa: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 115 Middle East & Africa: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 116 Recent Developments, by Company, 2017-2020

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Real-World Evidence Solutions Market Size, by Component, 2020 Vs. 2027 (USD Million)
  • Figure 8 Global Real-World Evidence Solutions Market Size, by Application, 2020 Vs. 2027 (USD Million)
  • Figure 9 Regional Snapshot: Real-World Evidence Solutions Market
  • Figure 10 Global Real-World Evidence Solutions Market Size, by Component, 2020-2027 (USD Million)
  • Figure 11 Global Real-World Evidence Solutions Market Size, by Application, 2020-2027 (USD Million)
  • Figure 12 Global Real-World Evidence Solutions Market Size, by End User, 2020-2027 (USD Million)
  • Figure 13 Global Real-World Evidence Solutions Market Size, by Country/Region, 2020-2027 (USD Million)
  • Figure 14 North America: Real-World Evidence Solutions Market Snapshot
  • Figure 15 Europe: Real-World Evidence Solutions Market Snapshot
  • Figure 16 Asia-Pacific: Real-World Evidence Solutions Market Snapshot
  • Figure 17 Key Growth Strategies Adopted by Leading Players, 2017-2020
  • Figure 18 Real-World Evidence Solutions Market: Competitive Benchmarking
Back to Top